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Abstract 
Long waiting times for non-emergency services are a feature of several publicly-funded health 
systems. A key policy concern is that long waiting times may worsen health outcomes: when 
patients receive treatment, their health condition may have deteriorated and health gains reduced. 
This study investigates whether patients in need of coronary bypass with longer waiting times are 
associated with poorer health outcomes in the English National Health Service over 2000-2010. 
Exploiting information from the Hospital Episode Statistics (HES), we measure health outcomes 
with in-hospital mortality and 28-day emergency readmission following discharge. Our results, 
obtained combining hospital fixed effects and instrumental variable methods, find no evidence of 
waiting times being associated with higher in-hospital mortality and weak association between 
waiting times and emergency readmission following a surgery. The results inform the debate on 
the relative merits of different types of rationing in healthcare systems. They are to some extent 
supportive of waiting times as an acceptable rationing mechanism, although further research is 
required to explore Zhether long Zaiting times affect other aspects of individuals¶ life.  
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Introduction 
Long waiting times for elective services are a prominent health policy issue in several OECD 
countries. They are prevalent in countries that combine public health insurance with low patient 
cost-sharing and constraints on capacity. They act as a non-price rationing mechanism which 
brings together the demand for and the supply of health services (Siciliani, Borowitz and Moran, 
2013; Martin and Smith, 1999). Long waiting times may induce some patients to receive treatment 
in the private sector more swiftly at a positive price or to give up the treatment, therefore reducing 
the demand for public treatment. Similarly, if waiting times are long, individuals may 
prospectively buy private health insurance and opt for the private sector. On the supply side, when 
waiting times are high, providers may work harder if motivated by altruistic concerns or subject to 
performance targets (Cullis, Jones and Propper, 2000; Iversen and Siciliani, 2011). 
A key concern with rationing by waiting is that waiting times may worsen health outcomes. 
Koopmanschap et al. (2005) provide alternative scenarios describing how waiting times may affect 
patients¶ health. For example, a patient may experience a health loss while waiting but her health 
might be restored if the treatment is effective. Alternatively, waiting times may affect not only 
patient¶s health, but also reduce treatment efficacy. If the patient waits too long, her health 
condition may have deteriorated so that treatment becomes less effective and health gains are 
reduced. 
Analysing the effect of waiting times on health outcomes while on the list is important to 
understand whether patient¶s health deteriorates during the wait but does not inform us if patient¶s 
ability to benefit from surgery is also affected. Our analysis complements previous literature 
(reviewed below) which looks at the effect of waits on patients health while on the list (e.g. if the 
patient dies while waiting or is admitted to hospital as an emergency before planned CABG 
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surgery) by investigating the effect of long waiting times on post-operative health outcomes. We 
measure health outcomes in terms of probability of (a) in-hospital mortality once admitted to the 
hospital for surgery, and (b) being admitted as an emergency for any cause in the 28 days 
following discharge from hospital after surgery.  
The study contributes to the policy debate on the relative merits of different types of rationing in 
healthcare systems. If waiting times affect health outcomes, policymakers should consider 
alternative rationing mechanisms or introduce policies which further encourage effective 
prioritisation.  
We focus on elective patients in need of a coronary bypass (CABG) in the English National Health 
Service (NHS). CABG is a common procedure for patients with serious heart conditions. Focusing 
on CABG is advantageous because (a) health outcomes can be unambiguously interpreted, as the 
risk of mortality and readmission is not negligible (more than 1% and about 4% respectively) and 
(b) CABG is nearly exclusively provided in the public sector, with the private sector performing 
only 2% of all heart surgeries, including CABG (Ludman, 2012). Therefore selection effects due 
to the private sector are likely to be negligible. 
We employ a large sample of all patients receiving coronary bypass during 2000-2010. During this 
period, waiting times dramatically reduced from 220 to 50 days (Figure 1). Such reductions, 
unique to the United Kingdom, are the result of several policies that combined additional resources 
with stringent maximum waiting-times targets (Smith and Sutton, 2013). Below we argue that 
such policies generated changes in waiting times over time and across hospitals and provide a 
unique opportunity to assess whether long waiting times are associated with worse health 
outcomes.  Although the reduction in waiting times through penalties may have also affected the 
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referral criteria of patients added to the list, we control for patients¶ severity with a range of 
indicators and by employing an instrumental-variable approach. 
Our analysis relies on three empirical strategies. First, for each year, we estimate patient-level 
linear probability models to analyse whether the probability of dying after admission (or being 
readmitted as an emergency) depends on waiting. Hospital fixed effects are included to control for 
variations in hospitals¶ resources and protocols Zhich may act as confounders. A key issue for 
identification relates to prioritisation (Gravelle and Siciliani,  2008b): more severe patients wait 
less and have higher risk of in-hospital mortality. We address this issue introducing a range of 
controls. Nonetheless, we cannot exclude that unobserved severity remains, correlated with 
waiting times and health outcomes. This limitation is addressed with our other approaches. 
Our second strategy exploits significant variations of waiting times over the years and across 
providers. We build a long panel with repeated observations at hospital level over eleven years. 
We test whether hospitals that experienced sharper reductions in waiting times resulted in better 
health outcomes by employing fixed-effects panel-data models, which control for time-invariant 
unobserved hospital heterogeneity. We account for time-varying unobserved factors by adopting 
an instrumental-variable approach. 
Our third strategy involves patient-level models exploiting the whole panel. Waiting times are 
again potentially endogenous due to unobserved severity. We instrument patient-specific waiting 
times with the waiting time at hospital level for CABG and for Percutaneous Transluminal 
Coronary Angioplasty (PTCA), a less invasive procedure. Waiting times for PTCA should be 
correlated with waiting times for CABG, but not with CABG health outcomes, once we control for 
hospital characteristics. 
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Our results from panel-data models suggest no association of CABG waiting times with in-
hospital mortality. Instead long CABG waiting times are associated with an increase in emergency 
readmission rates (although this effect has weak statistical significance). This is also generally the 
case when we employ patient-level regressions.  
 
Literature 
Limited evidence exists on whether waiting times affect post-surgery health outcomes of elective 
patients. Most studies are from the medical literature and focus on CABG. They tend to be small-
scale studies with samples from selected providers. Légaré et al. (2005) and Carriér et al. (1993) 
find that CABG waiting times in Canada do not predict the probability of dying during 
hospitalization or other adverse outcomes (i.e. length of stay in intensive care units). Sari et al. 
(2007) compare health outcomes for CABG patients who waited less or more than 7 days and find 
no difference in morbidity, in-hospital mortality and adverse cardiac events. Sampalis et al. (2001)  
employ a sample of 266 patients in three hospitals and find no association between waits and 
mortality after surgery but evidence of reduced physical functioning, vitality and other indicators 
for long waiters (more than 97 days). Rexius et al. (2005) conclude that there is no evidence that 
prolonged CABG waits increase post-operative mortality in two Swedish hospitals. We follow the 
medical literature in measuring health outcomes as in-hospital mortality and probability of a post-
surgery emergency admission. However, we employ a much larger sample, which includes the 
whole population of CABG patients over eleven years in England. 
Sobolev and Fradet (2008) provide a review of the literature for CABG and suggest that long waits 
may worsen symptoms and clinical outcomes. Waits may also increase the probability of pre-
operative death (while waiting) and unplanned emergency admission (Rexius et al., 2004; Sobolev 
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et al., 2006, 2012; Sobolev and Kuramoto, 2010). The main difference of these studies with ours is 
the focus on the experience of patients while waiting, as opposed to their health once admitted for 
surgery, which is instead our focus. 
There is an analogous literature that investigates the impact of waits for hip or knee replacement 
(Hajat et al., 2002; Fienden, 2005; Hirvonen et al., 2007a; Tuominen, 2013), suggesting that long 
waits are not associated with higher mortality and this is due to the low mortality risk. Some 
analyses find however an effect of long waits on quality of life. The systematic review by 
Hoogeboom et al. (2009) concludes that there is strong evidence that pain does not worsen during 
a six-month wait (Hirvonen, 2007b, for an earlier review). Self-reported functioning also does not 
deteriorate for patients awaiting a hip replacement, while the evidence is conflicting for knee 
replacement. While most studies have modest sample size, Nikolova et al. (2015) employ all 
patients undergoing four common procedures (hip and knee replacement, varicose veins and 
inguinal hernia) in English NHS hospitals for which Patient-Reported Outcome Measures 
(PROMs) are available and linked to HES. They find that long waits reduce health-related quality 
of life for hip and knee replacement patients. No evidence is found for varicose veins and inguinal 
hernia.   
In the economics literature, Hamilton et al. (1996) analyse the impact of waits following hip 
fracture on the probability of death and further hospitalisation in Canada, finding no effect. A 
similar result for England is obtained by Hamilton and Bramley-Harker (1999). Hamilton, Ho and 
Goldman (2000) compare waiting times and outcomes in the US and Canada. Although waits are 
longer in Canada, they do not affect mortality rates. These studies differ from ours since they deal 
with waiting times following hip fracture that are very short (less than a week), as opposed to 
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much longer waiting times for CABG surgeries (weeks or months). Our focus is on elective care, 
where waiting times are notoriously long.  
 
Institutional background 
Waiting times have been persistent in the British NHS since its inception. The NHS provides 
universal access to healthcare and is funded by taxation and free at point of use. Local purchasers 
receive budgets from central government. Family doctors act as “gatekeepers” to specialist care. 
Patients need a referral to access a specialist. Most hospital care is provided by public hospitals, 
which are separate from the purchasers. Hospitals are subject to regulatory control and receive a 
fixed price per patient treated. In 2003 private providers entered the market but treat a small 
proportion (2%) of NHS patients.  
The 2000 NHS Plan recognised that the health system was underfunded relative to other European 
countries and had long waits. The intention has been to provide considerably extra funding in 
exchange of marked improvements in performance, in particular in relation to waiting times 
(Smith and Sutton, 2013). Such increase in resources is likely to be a key determinant in the 
observed reductions in waiting times. While maximum waiting-time guarantees have been 
implemented for at least 20 years, it was only from 2000 that sanctions were introduced for 
hospitals not satisfying such targets, which contributed to substantive reductions in waiting times 
(Propper et al., 2008).  
In the English NHS, patients who need to see a specialist are usually referred by a General 
Practitioner (GP) to a hospital. Patients with symptoms of coronary artery disease (e.g. chest pain) 
are referred to a cardiologist. Direct access to hospital specialists is only possible through the 
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Accident and Emergency department for emergency patients. At the time of the referral, patients 
have the right to choose which hospital to go for their outpatient appointment and the consultant-
led team who will be in charge of the patient in the first appointment at the hospital.  
During the outpatient visit, the cardiologist assesses the health conditions and chooses the 
appropriate treatment. She may perform a non-surgical procedure to unblock the artery. If this fails 
the patient is referred for a CABG, usually performed by a cardiac surgeon, and placed on the 
waiting list (Gaynor et al, 2012). This is the time we start to calculate the wait. During the wait, a 
pre-assessment clinic appointment is arranged to prepare the patient for surgery and give her the 
opportunity to ask questions. The surgeon reviews patient¶s medical history and does a physical 
check. The wait ends when the patient enters the hospital for the treatment. We are not aware of a 
formal urgency categorization to prioritise patients on the list, neither of corresponding 
recommended maximum waiting times for different groups, though that does not imply that 
doctors prioritise patients informally on the list.  
 
Methods 
We employ three specifications, whose advantages and drawbacks are outlined below. 
Patient level analysis ± cross-section 
For each financial year, we estimate a patient-level specification using a linear probability model 
(LPM):  
 ijjijijij Swm embba  21 )log(  (1) 
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where ijm  is a binary variable equal to one if patient i died (or was readmitted as an emergency 
following surgery) in hospital j, ijw  is waiting time, ijS is a vector of measures of patients¶ severity 
and other controls, ije is the idiosyncratic error term. jm is a hospital fixed effect, which controls 
for hospital unobservables (differences in resources, demand conditions, protocols and quality). 
Our key interest is in estimating 1b . Failing to control for severity may lead to (downward) bias 
estimates because (a) mortality risk depends on patients¶ pre-operative severity and (b) more 
severe patients are prioritised and wait less. To account for this we include a large set of 
covariates. The identification strategy relies on residual unobserved severity being negligible.  
We run Equation (1) for each year. Waiting times have changed over time and the relation 
between waiting and health outcomes may also have changed.   
The models are estimated with Ordinary Least Squares (OLS), allowing for clustered standard 
errors at hospital level. The advantage of LPMs is that we can interpret the coefficients as 
marginal effects (Angrist and Pischke, 2008). We also estimated fixed-effects logit regressions but 
results were similar.  
      
Hospital level analysis ± panel data  
Our second specification employs data aggregated at hospital level: 
 jtjtjtjt Sw emmbba  21jt )log(m   (2) 
where jtm  is the mortality (or readmission) rate in hospital j in year t, jtw  (mean) waiting time, 
jtS is a vector of variables which includes severity and other controls and jte is the error term. tm  
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includes year dummies allowing for a time trend (e.g. due to technology). jm  is a hospital fixed 
effect controlling for time-invariant unobservables.  
To obtain an unbiased estimate of 1b  we exploit large variation in waiting times over time and 
across hospitals. We argue that such changes can be considered exogenous, since they were driven 
by general policy initiatives rather than specific ones on coronary bypass or aimed at specific 
hospitals. Additionally, by estimating a fixed effect model, we are able to control for time-
invariant confounding factors, such as hospital organization, that could impact both waiting times 
and health outcomes.  
Even if we control for unobservables at hospital level, there may be concurring events (e.g. other 
policy initiatives) that lead to omitted-variable bias. For example, the introduction of penalties for 
hospitals not respecting maximum waiting times may have contributed to the reduction in waiting 
times but also in the referral criteria to add patients on the list. We control for this possibility by 
instrumenting CABG waiting times with PTCA waiting times: waiting for PTCA should be 
correlated with waiting for CABG, but not with CABG mortality or emergency readmission rates 
(in Robustness Checks section we test for possible substitution between CABG and PTCA). 
Under this approach 1b  can be interpreted as the effect of waiting times on health outcomes due to 
variation “Zithin” hospitals. 
 
Patient level analysis ± panel data  
We extend our analysis by running the following patient-level specification:  
 ijtjtijtijtijt Swm emmbba  21 )log(  (3) 
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This model is analogous to (1) but it estimated using all years. Like (2), it exploits variations 
across hospitals and years. Like (1), Equation (3) could be subject to omitted-variable bias, if in 
each year patients with higher severity wait less and have a higher risk of mortality (or 
readmission). To address this form of endogeneity, Ze control for patients¶ severity using the 
extensive controls employed in (1) and we instrument the patient-level waiting times, w ijt  , with 
the mean wait in each hospital and in each year for both CABG and PTCA, i.e. we use 
,
w jt CABG  
and 
,
w jt PTCA  as instruments. Since aggregated CABG waiting times are constructed using 
individual waiting times, it is reasonable to assume a strong positive correlation between (hospital-
level) aggregated waits and the individual (patient-level) waits. Moreover, there is no reason to 
believe that aggregated waiting times are correlated with in-hospital mortality (or emergency 
readmission) once Ze control for patient¶s severity and hospital (unobserved) characteristics. A 
similar reasoning could be applied to (hospital-level) aggregated PTCA waiting times, which are 
expected to be correlated Zith patient¶s health status only through patient¶s Zaiting time for 
CABG surgery.  
 
Data 
The analysis uses the Hospital Episode Statistics (HES). This is an administrative data set which 
contains records of all inpatient admissions, outpatient appointments and Accident & Emergency 
attendances at English NHS hospitals. HES are secondary data collected by the Health and Social 
Care Information Centre. All patient level data are anonymised and no personal information is 
included. No ethical approval has been required to conduct the analysis since the project does not 
involve patients directly and patients are not identifiable from the data.  
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We use data for 11 financial years (April-to-March) between 2000-01 and 2010-11. Our sample 
includes all patients (elective inpatient admissions) who had a CABG surgery (OPCS-4 codes 
K40-K46). We exclude 30,486 patients for whom CABG was combined with PTCA and/or a heart 
valve procedure. These procedures can be substitutes or complements to CABG and contribute to 
mortality risk.  
From this original sample of 150,805 CABG patients, we lose 92 patients without a valid hospital 
identifier and 7,276 patients with invalid waiting times (either missing or larger than two years). 
We exclude 10,085 patients treated in hospitals performing less than 20 CABG in a year. We drop 
186 patients younger than 34 or older than 95 years. The final sample includes 133,166 patients. 
For each patient we construct (a) a dummy equal to one if the patient dies in hospital between 0-29 
days (inclusive) from admission for the first eligible procedure in the spell in the respective 
financial year; (b) a dummy if the patient is re-admitted as an emergency within 28 days following 
CABG surgery. These are our dependent variables measured at patient and hospital level.  
(Inpatient) waiting time is the difference between the time the patient is added to the list, following 
specialist assessment, and the time the patient is admitted for surgery (Dixon and Siciliani, 2008). 
2ur control variables include patients¶ age, gender, number of diagnoses at admission, number of 
past emergency admissions to NHS hospitals the year preceding the surgery and the Charlson 
index (Charlson et al, 1987), which is a powerful predictor of 10-year mortality risk. We employ a 
proxy of patient¶s socioeconomic status built on income domain of Indexes of Multiple 
Deprivation (IMD) 2004, 2007 and 2010: the proportion of population living in low-income 
households in the LoZer Super 2utput Area (LS2A) of patient¶s residence (Noble et al., 2004). 
The distribution of this indicator is split into five quintiles. We do not have explicit measures of 
prioritisation collected on a routine basis. 
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Table 1 provides descriptive statistics. On average, the waiting time for CABG is 107 days. 
Waiting times have reduced over the years (Figure 1). In 2000, a CABG patient waited more than 
7 months before having a surgery, but only 2 months in 2010. The reduction was more substantive 
in 2000-2005 and then relatively stable.  
In addition to a large overall variation, waiting times for CABG varied significantly within each 
hospital over the years. Such variation is important since fixed-effects models rely on this 
variability.  A graphical representation of this variability is in Figure 2, which shows the mean 
waiting time distribution across hospitals over 11 years. There is large variability in waits both 
between (standard deviation is 46.74) and within hospitals (standard deviation is 107.33).   
In-hospital mortality and emergency readmission rates have been stable at around 1.2% and 4.1% 
respectively. The average age is 65 years. 8% of patients have no comorbidities; more than half 
have at least five concurrent diagnoses. 82% are men. On average, patients had 0.27 emergency 
hospitalizations in the year preceding surgery. 
Results 
Table 2 provides the results for the patient-level analysis, as in Equation (1). All models include 
hospital fixed effects. Column (1) has no controls, while column (2) include all controls.  
Our key results show that for all years (except for 2003) there is no association between waiting 
times and in-hospital mortality. For 2003, we find instead that longer waits are associated with a 
reduction in mortality. A 100% increase in waiting times (doubling the wait) reduces the 
probability of mortality by 0.23 percentage points (with an underlying risk of mortality of 1%). In 
2003 waiting times were still high (100 days) and prioritisation was more likely to be pronounced. 
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A long Zait may indicate that patient¶s severity is loZ. This counter-intuitive result may therefore 
be due to waiting times acting as a residual indicator of urgency, even after extensive severity 
controls.  
When health outcomes are measured as probability of emergency readmission following surgery, 
we find a positive association (except for 2002, 2004 and 2010 when negative) but generally not 
statistically significant. The only exception is 2006 with a positive and statistically significant 
coefficient: an increase in waiting times by 100% increases the risk of an emergency readmission 
by 0.32 percentage points. 
Table 2 does not report coefficients on control variables, which are available in the on-line 
Appendix. [INSERT LINK TO ONLINE FILE A] The sign of the coefficients are as expected. 
The risk of mortality and readmission generally increases with age, number of diagnoses, past 
utilization and Charlson index. 
Tables 3a and 3b provide the results for the hospital-level analysis (using unbalanced and balanced 
sample). In Table 3a we find that waiting times are not associated with in-hospital mortality. The 
control variables are generally insignificant, Zhich is not surprising given that patients¶ case-mix 
is unlikely to vary significantly over time for a given provider. Table 3b instead suggests a positive 
association between waiting times and the probability of an emergency readmission, although the 
coefficient is significant at 10% level only when additional controls are included. An increase in 
waits by 100% increases readmission rates by 0.49 percentage points. Given a baseline risk of 
4.05%, doubling waiting times increases the risk of readmission from 4.05% to 4.54%. The effect 
appears therefore relatively modest. 
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Most waiting time reductions happened between 2000 and 2005 (Figure 1). The results may be 
biased towards zero if waits varied to a lower extent after 2005. In Tables 4a and 4b we split the 
sample in two sub-periods 2000-2005 and 2006-2010. We do not find an association of waiting 
times with mortality (Table 4). On the contrary, we find a positive and significant association of 
waiting times on emergency readmissions only during 2006-2010.  
Another concern is that time trends in CABG mortality may differ across hospitals. To test this 
hypothesis, we interact hospital fixed effects with a linear time trend alloZing each hospital¶ 
mortality to vary differently over time. Results, available from the authors, are similar to those in 
Table 4. 
While fixed effect models control for time-invariant unobserved heterogeneity at hospital level, 
some residual endogeneity may persist if worse outcomes lead providers to change (possibly 
reduce) waiting times. We account for this by employing an instrumental variable (IV) approach 
(results in Table C of online Appendix [INSERT LINK TO ONLINE FILE B]). The first-stage 
regression suggests that waiting time for PTCA is a good predictor of waiting time for CABG. The 
second-stage results confirm that CABG waiting times are not associated with mortality and 
emergency readmissions. 
One advantage of Equation (2) is that it allows focusing on exogenous variations in waits over 
time within hospitals. On the other hand, it may suffer from aggregation bias. To address this 
issue, we employ the specification in Equation (3) running a patient-level regression using the 
sample over 11 years, and instrument patient-level waiting times with hospital-level waiting times 
for CABG and PTCA. Table 5 provides the results when we do not account for endogeneity. We 
find that longer waiting times are associated with lower probability of dying after admission. This 
can be explained by unobserved heterogeneity (note that in the patient-level analysis most of the 
16 
 
coefficients are negative, see Table 2). In contrast, we find that waiting times is not associated 
with emergency readmission. This is consistent with Table 2, where most coefficients are positive 
but not significant.  
The IV results are reported in Table 6. The first-stage estimates show that the mean CABG waiting 
time ( w jt ) strongly predicts individual waiting time w ijt  (p-value close to zero), both when it is 
the only instrument and also when combined with mean PTCA waiting time (which varies by year 
and hospital). The F-statistic is well above the critical value, suggesting that the instruments are 
jointly significant. The second-stage results are consistent with those from Equation (2). The effect 
of waiting times on in-hospital mortality is negative and, differently from Table 5, not significant, 
indicating that when individual heterogeneity and unobserved severity are accounted for, waiting 
times do not affect the probability of death. On the contrary, the effect of waiting times on 
emergency readmission is still significant (at 10% level). The size of the coefficient is comparable 
to the one derived in Table 3b. An increase in waiting times by 100% increases readmission rates 
by 0.35 percentage points, which translates in an increase in the risk of readmission from 4.05% to 
4.40%. Again, the effect appears modest. 
Since we have two instruments, we can run the over-identification test and compute Hansen J-
statistic. The high p-value demonstrates that the instruments are valid and correctly included as 
exclusion restrictions.  
In summary, our key results are robust to alternative specifications. The result that longer waits 
affect weakly emergency readmission rates without producing any effect on mortality seems 
plausible. Mortality is a more extreme outcome than readmissions. It may be that longer waits 
deteriorate patients¶ health, but not enough to impair her survival rate.  
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Robustness Checks 
A potential source of bias is selection into treatment due to waiting times: in response to long 
waits, some patients may be admitted as emergency or receive an alternative treatment, such as 
PTCA. To test whether the choice of elective CABG is uncorrelated with waiting times, we (a) 
replicate the analysis measuring the mortality rate for all CABG patients, including emergency 
ones; (b) test directly whether waiting times are positively associated with the proportion of 
patients admitted as an emergency and (c) test whether waiting times for CABG affect the 
proportion of patients who receive PTCA (as a ratio of total CABG and PTCA patients). Table 7 
shows that the results are qualitatively similar when we use the mortality rate for all patients 
(elective and emergency). We find no evidence of hospitals admitting more CABG emergency 
patients or of substituting CABG with PTCA when waiting times are longer.  
Since waiting times have a skewed distribution, we test whether our hospital-level results change 
when we replace the mean hospital wait with the median wait (which is shorter) and the 90th 
percentile of each hospital wait distribution in each year. Table 8 suggests that there is no 
association between waiting time and in-hospital mortality. The association between waiting times 
and emergency readmission is more statistically significant when waiting time is measured at the 
90th percentile.  
If hospitals differ in the volume of CABG patients, our estimates will be less precise. We already 
excluded hospitals performing less than 20 surgeries per year. As an additional check we re-
estimated the models using the number of CABG surgeries in each year and hospital as weights. 
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The estimated coefficients are coherent with our baseline specification (available from the 
authors). 
We discuss some possible limitations. We exploit variation in waiting times in 2000-2010. Several 
policies have been implemented during this period (e.g. more reliance on prospective payment 
systems, competition and enhanced choice). Our results may be biased if different hospitals 
responded differentially to these policies over time. For example, good hospitals may respond to 
competition policies by attracting more severe patients and higher demand, therefore increasing 
waiting times. A bias may arise only if changes in severity are unobserved. We control for a range 
of severity measures. Moreover, Gaynor et al (2013) find that competition had no effect on waiting 
time. Such bias is therefore unlikely.  
A prospective payment system was introduced in 2003/2004, which links payments to hospital 
activity. This policy makes profitable for hospitals to up-code secondary diagnoses and label 
patients as more severe. However, we use information on total number of diagnoses and not on the 
type of diagnosis, which might instead proxy the severity of concurrent illness. As a check, we run 
Model (3) setting the maximum total number of diagnoses to the pre-reform level, and the results 
are unchanged. Our results are unlikely to be affected by the change in the payment system.   Also, 
as mentioned, we run sensitivity checks allowing for a linear trend for each hospital, which will 
capture differential hospital responses to policies introduced over the period.  
We treat mortality and emergency readmissions as independent outcomes. Using data on 
emergency admissions for hip fracture, Laudicella, Li Donni and Smith (2013) show that measures 
of emergency readmissions may be biased if they do not take into account that higher readmissions 
may depend on patients¶ survival. 2ur analysis finds that Zaiting times are never associated Zith 
mortality and therefore the association between waits and emergency readmissions is unlikely to 
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be biased. We also test for selection due to mortality by running a Heckman selection model on 
patient-level data for readmissions conditional on patient¶s survival. The inverse Mills ratios are 
not significant and the results are similar to those without accounting for selection (available from 
the authors). Survivorship bias may be more relevant for emergency patients than elective ones.  
Finally, if patients are dying while waiting, there may be a potential issue of selectivity through 
mortality on the list. Our data does not contain information on mortality while waiting. However, a 
review of the previous literature on CABG waiting times suggests that the mortality rate for 
patients waiting for the surgery is low and ranges between 0.5% to 2.6% (Koomen et al. 2001; 
Carrier et al. 1993) and this risk includes also deaths occurred for reasons unrelated to cardiac 
events.  
 
Conclusions 
Waiting times are a major health policy issue. Previous work showed that waiting times act as a 
rationing mechanism to bring demand for and supply in equilibrium. We still do not know whether 
rationing by waiting is an efficient and desirable rationing mechanism compared to others (such as 
co-payments and direct rationing).  
A key policy concern with rationing by waiting is that prolonged waiting times may worsen health 
outcomes following surgery. This study contributes to the limited empirical evidence that informs 
this question. It shows that for coronary bypass variations in waiting times may lead to variations 
in health outcomes as measured by emergency readmission rates. No positive and significant 
association is found with in-hospital mortality.  
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Our results are important for policy and contribute to the understanding of the role and relative 
merits of different forms of rationing within publicly-funded systems. In the presence of excess 
demand, health care can be rationed in at least three different ways. One possibility is to introduce 
co-payments. Rationing by price implies that those patients who seek treatment can obtain it 
without significant waits, and therefore their health outcomes will not be affected. On the other 
hand, positive prices may deter some patients (those who are poor and sick) from seeking 
treatment, and therefore health outcomes for those may be reduced because of lack of adequate 
treatment. Rationing by waiting is less likely to deter poor patients from seeking treatment but 
long delays may potentially affect health outcomes. Another difference is that while higher co-
payments raise additional resources for the funder, waiting times do not (Gravelle and Siciliani, 
2008a) though when waiting times are short, an increase in waiting times may help to reduce cost 
of provision by reducing idle capacity (Siciliani, Stanciole and Jacobs, 2009). A third possibility is 
to implement µdirect¶ rationing Zhere doctors refuse treatment to some patients based on loZ 
clinical need. This implies the existence of clear prioritisation rules and protocols, which is only to 
some extent observed in practice (and can be politically unsustainable). In practice, these three 
forms of rationing can co-exist. For example, an increase in waiting times could induce hospitals 
to reduce referrals for surgery by suggesting instead medical treatments. 
Our results are to some extent supportive of waiting times as an acceptable rationing mechanism 
since waiting times do not appear to be associated with extreme measures of health outcomes such 
as in-hospital mortality and only to some extent with emergency readmissions. This may be 
interpreted as a sign that prioritisation works well within the NHS. We cannot however exclude 
that the quality of life of CABG patients is reduced when waiting times are long. Mortality and 
emergency readmission are extreme negative outcomes and therefore capture only one end of the 
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distribution. For relatively healthier patients who do not die in hospital or are not admitted as an 
emergency, waiting times may still worsen health outcomes. Testing whether this is the case 
would require more refined outcome measures that are generally not available from large routine 
administrative databases (the only exception, to the best of our knowledge, is Sampalis et al., 
2001, which tests Zhether long Zaits affects patients¶ Tuality of life though Zith a sample of 266 
patients in three hospitals). This could be an interesting issue to explore in future research. It may 
also be interesting to test the effect of waiting times on health outcomes for conditions with 
different degree of urgency, including more urgent procedures (e.g. cancer patients) or less urgent 
ones (e.g. cataract surgery).  
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               Table 1: Descriptive Statistics. CABG elective patients: 2000/01-2010/11 
Variables Mean Standard Min Max 
Individual Level Variables (sample size =133,166)  
Patient died in hospital  0.0117 0.1073 0 1 
Patient had an emergency readmissions within 28 days from discharge 0.0407 0.1975 0 1 
Waiting time (days)   106.97  110.82 1 728 
Waiting time (days) in 2000-05 139.16
  
128.57         1 728 
Waiting time (days) in 2006-10 57.85
      
42.51 1 643 
Age     
   35-44 years old  0.0197 0.1390 0 1 
   45-54 years old 0.1190 0.3238 0 1 
   55-64 years old 0.3185 0.4659 0 1 
   65-74 years old      0.3977      0.4894 0 1 
   75-84 years old 0.1423 0.3494 0 1 
   85-94 years old 0.0028 0.0526 0 1 
Male patient 0.8222 0.3823 0 1 
Number of diagnoses at admission     
  one diagnosis   0.0804 0.2719 0 1 
  two diagnoses     0.0780 0.2681 0 1 
  three diagnoses 0.1169 0.3212 0 1 
  four diagnoses 0.1422 0.3492 0 1 
  five diagnoses 0.1479 0.3550 0 1 
  six diagnoses 0.1384 0.3453 0 1 
  seven diagnoses 0.1256 0.3314 0 1 
  more than seven diagnoses 0.1708 0.3763 0 1 
Number of past emergency admissions 0.2698 0.6352 0 41 
Charlson Comorbidity Index  0.5768
  
0.8520
          
0 10 
Income Deprivation Score (quintiles)     
   least income deprived quintile 0.2224 0.4158 0 1 
   2nd income deprived quintile     0.1825 0.3862 0 1 
   3rd income deprived quintile     0.1972 0.3979 0 1 
   4th income deprived quintile    0.2056 0.4041 0 1 
   most income deprived quintile  0.1924 0.3942 0 1 
Provider Level Variables (sample size = 324) 
Average waiting time (days) 97.32 62.37 7.21 328.98 
Average patients¶ age  64.94 1.23 61.21 68.02 
Average number of diagnoses per patient 5.32 1.93 1.00 11.56 
Proportion of male patients 0.8227 0.0315 0.4742 0.8947 
Number of past emergency admissions  0.2685 0.0689 0.0263 0.5046 
Proportion of patients who died in hospital 0.0118 0.0078 0 0.0695 
Proportion of patients with emergency readmissions 0.0405 0.0130 0 0.0867 
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Table 2: Patient Level Analysis. Cross-Section Models.  
Effect of waiting times on mortality and readmissions 
 
Year Sample Size Dependent variable:  in-hospital mortality 
Dependent Variable: 
emergency readmission 
  (1) (2) (1) (2) 
      
2000 13,646 -0.0002987 -0.0000842 0.0005680 0.0002792 
  [-0.34] [-0.10] [0.42] [0.21] 
2001 13,837 -0.0007831 -0.0007331    0.0020397 0.0017898 
  [-1.14] [-1.13] [1.24] [1.12] 
2002 14,104 -0.0015086       -0.0018849* -0.0003972     -0.0010744 
  [-1.53] [-1.97] [-0.28] [-0.78] 
2003 13,654 -0.0015245* -0.0022725*** 0.0030209* 0.0024057 
  [-1.90] [-2.81] [2.01] [1.51] 
2004 13,593 -0.0004476       -0.0008855    -0.0008238 -0.0010015 
  [-0.44] [-0.84] [-0.51] [-0.61] 
2005 11,614 0.0004950 -0.0002925    0.0014051 0.0008729 
  [0.48] [-0.26] [0.70] [0.44] 
2006 11,151 0.0002042 -0.0007617    0.0038495** 0.0032247* 
  [0.14] [-0.51] [2.32] [1.92] 
2007 11,844 0.0013930 0.0009229    0.0000530 0.0004030 
  [1.37] [0.99] [0.02] [-0.17] 
2008 11,429 -0.0015440 -0.0022566    0.0008658 0.0005588 
  [-1.14] [-1.65] [0.42] [0.27] 
2009 9,655 0.0000941 -0.0005145    0.0020787 0.0009075 
  [0.06] [-0.33] [0.81] [0.35] 
2010 8,639 -0.0011555 -0.0016716    -0.0002173 -0.0008502 
  [-0.68] [-0.96] [-0.07] [-0.29] 
      
Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics are shown in brackets. Linear probability models with clustered 
robust standard errors. All specifications include hospital fixed effects. Specification (1) includes no control variables. 
Specification (2) includes patient¶s age at admission, gender, the number of diagnoses at admission, the number of 
emergency hospitalizations in the previous 365 days (for any cause) and income quintiles.  
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Table 3a: Hospital Level Analysis. Panel Data Models.  
Effect of waiting times on mortality 
 
 Dependent variable: in±hospital mortality rate 
 Unbalanced Sample Balanced Sample 
 (1) (2) (1) (2) 
     
log(waiting times) -0.0008503 -0.0004554 0.0016345 0.0021272 
 [-0.42] [-0.25] [1.09] [1.35] 
Charlson Index  0.0063638  0.0075576 
  [1.11]  [0.96] 
male patients  -0.0100155  -0.0236277 
  [-0.77]  [-1.02] 
patients¶ age  0.0023973*  0.0018882 
  [1.68]  [1.00] 
n of diagnoses  -0.0005961  -0.0005331 
  [-0.84]  [-0.68] 
income deprivation  0.0144657  0.0243816 
  [0.38]  [0.51] 
past hospitalizations  0.0037953  0.0137693 
  [0.31]  [0.91] 
constant 0.0187076* -0.1303792 0.0059890 -0.1041939 
 [1.73] [-1.35] [0.60] [-0.82] 
hospitals FE yes yes yes yes 
     
Observations 324 220 
Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics in brackets. Fixed-effects model including  
year dummies; standard errors clustered at hospital level.  
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Table 3b: Hospital Level Analysis. Panel Data Models.  
Effect of waiting times on readmissions 
 
 Dependent variable: emergency readmission rate 
 Unbalanced Panel Balanced Panel 
 (1) (2) (1) (2) 
     
log(waiting times) 0.0057596** 0.0048840* 0.0035729 0.0035660 
 [2.64] [1.88] [1.55] [1.52] 
Charlson Index  0.0015954  0.0075049 
  [0.21]  [0.93] 
male patients  0.0217516  0.0065585 
  [0.74]  [0.14] 
patients¶ age  0.0012880  0.0029504** 
  [0.96]  [2.57] 
n of diagnoses  0.0003138  0.0007106 
  [0.31]  [0.63] 
income deprivation  0.2264362**  0.2777286** 
  [2.61]  [2.41] 
past hospitalization  -0.0041702  -0.0002132 
  [-0.23]  [-0.01] 
constant 0.0093396 -0.1176979 0.0204009 -0.2148450** 
 [0.81] [-1.26] [1.69] [-2.50] 
hospitals FE yes yes yes yes 
     
Observations 324 220 
Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics in brackets. Fixed-effects model including year 
dummies; standard errors clustered at hospital level.  
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Table 4: Hospital Level Analysis. Panel Data Models in two sub-periods.  
  Effect of waiting times on mortality and emergency readmission  
 
 Dependent variable: 
 in-hospital mortality rate emergency readmission rate 
 2000-05 2006-10 2000-05 2006-10 
     
log(waiting times) -0.0013290 0.0032361 0.0041493 0.0095292** 
 [-0.44] [1.06] [1.06] [2.37] 
Charlson Index 0.0133009* 0.0205238* -0.0012584 -0.0105682 
 [1.74] [1.99] [-0.15] [-0.57] 
male patients -0.0107531 -0.0147130 0.0112005 0.0406979 
 [-0.31] [-1.59] [0.21] [1.33] 
patients¶ age 0.0042726* -0.0005928 0.0014022 0.0038950** 
 [1.84] [-0.44] [0.73] [2.15] 
n of diagnoses -0.0003913 -0.0016946 0.0009951 0.0006015 
 [-0.28] [-1.27] [0.81] [0.27] 
income deprivation 0.0687616 0.0381129 0.0199846 0.3594544** 
 [0.52] [0.57] [0.11] [2.37] 
past hospitalization 0.0050440 0.0029481 -0.0106507 -0.0190434 
 [0.27] [0.24] [-0.44] [-0.68] 
constant -0.2554769 0.0424847 -0.0839738 -0.3302220** 
 [-1.53] [0.45] [-0.58] [-2.38] 
hospitals FE yes yes yes yes 
year dummies 2001-05 yes no yes no 
year dummies 2007-10 no yes no yes 
Observations 175 149 175 149 
       Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics are shown in brackets.  
       Unbalanced panel. Fixed-effects model with standard errors clustered at hospital level.  
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Table 5: Patient Level Analysis. Whole Panel. 
Effect of waiting times on mortality and readmissions 
Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics in brackets. Fixed-effects model including year dummies, 
with standard errors clustered at hospital level. Column (1) includes no control variables. Column (2) includes 
additional controls (see Table 2).   
 
 
Table 6: Patient Level Analysis. Whole Panel. 
FE Instrumental Variable Model 
 
 
CABG waiting times as 
IV 
CABG and PTCA waiting 
times as IV 
First stage 
  
   log(CABG wt) 1.112029*** [26.08] 1.106934*** [26.59] 
   log(PTCA wt)  0.0554588* [1.74] 
   F-statistic  680.23 (0.0000) 360.22 (0.0000) 
Second stage ± dependent variable: in-hospital mortality 
   log(wt) 0.0029032 [1.40] 0.0028265 [1.37] 
   overidentification test  0.662 (0.4160) 
   endogeneity test 2.736 (0.0981) 2.280 (0.1311) 
Second stage ± dependent variable: emergency readmission 
   log(wt) 0.0036514* [1.85] 0.0035337* [1.81] 
   overidentification test  
 
1.843 (0.1746) 
   endogeneity test 2.207 (0.1374) 1.604 (0.2053) 
Observations 133,166 133,035 
Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics in brackets. Fixed effects instrumental variable model 
including all control variables and year dummies. The F-statistic for the significance of the exclusion 
restriction(s) is distributed as a chi-squared with one (two, in the last specification) degree of freedom, under 
the null. The endogeneity test provides the Hausman statistic testing the null hypothesis that the baseline and 
IV estimates are the same. Under the null, the statistic is distributed as a chi squared with one degree of 
freedom. The over-identi¿cation test provides the Hansen J statistic for the joint validity of instruments.  
 
Dependent variable:  
in-hospital mortality 
Dependent variable: 
emergency readmission 
  (1)  (2) (1) (2) 
     
log(waiting time) -0.0005946* -0.0007689*** 0.0012020** 0.0007985 
 [-2.02] [-2.70] [2.46] [1.63] 
hospitals FE yes yes yes yes 
     
Observations 133,166 133,166 133,166 133,166 
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Table 7: Hospital Level Analysis. Robustness Checks. 
 
 In-hospital mortality 
rate for elective and 
emergency  
CABG patients 
Proportion of 
emergency CABG 
patients 
Proportion of 
PTCA patients 
    
log(waiting times) -0.0017926 -0.0053354 0.0204818 
 [-1.00] [-0.73] [0.96] 
hospitals FE yes yes yes 
    
Observations 324 324 318 
Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics in brackets. Unbalanced panel. Fixed-effects 
 model including year dummies with standard errors clustered at hospital level.  
 
 
Table 8: Hospital Level Analysis. Additional Robustness Checks. 
 Average waiting time Median waiting time 90
th
 percentile of waiting 
time distribution 
 
In-hospital 
mortality 
Emergency 
readmission 
In-hospital 
mortality 
Emergency 
readmission 
In-hospital 
mortality 
Emergency 
readmission 
log(waiting 
times) -0.0004554 0.0048840* -0.0011880 0.0028426 0.0007398 0.0065304** 
 [-0.25] [1.88] [-1.07] [1.32] [0.29] [2.57] 
hospitals FE yes yes yes yes yes yes 
Observations 324 324 324 324 324 324 
Notes: * p <0.10, ** p<0.05, *** p<0.01. t-statistics are shown in brackets. Unbalanced panel. Fixed-effects model 
including year dummies with standard errors clustered at hospital level. 
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